Zymeworks Inc Sustainability Reports
Zymeworks Inc. is a clinical-stage biopharmaceutical company that designs, develops, and commercializes multifunctional biotherapeutics. Its primary focus is on engineering next-generation antibody-based therapies for the treatment of cancer and other difficult-to-treat diseases.
Sector: Professional & technical services
Country: Canada
Exchange: Nasdaq
LEI: 894500AHOYAGYLYZJL67
FIGI: BBG019XSYC98
2 reports from 2018 to 2025